Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (211-220 of 518) with videos related to

Pageof 52
Sort By:
Journal of Psychiatric Research|November 21, 2025
Prevalence of dermatologic side effects of mood stabilizers in bipolar disorder: A systematic review and meta-analysisFrancesca Pampaloni, Mete Ercis, Dawn Marie R Davis, et al.
Biological Psychiatry|February 8, 2025
A Critical Role of Philanthropic Support in Paving the Way to Precision Medicine for Bipolar DisorderDaniel L Pham, Emily G Baxi, Kelsey M Barcomb, et al.
Neuropharmacology|May 23, 2012
Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1David J Hinton, Moonnoh R Lee, Taylor L Jacobson, et al.
The American Journal of Psychiatry|March 2, 2016
Potential Risks of Poorly Monitored Ketamine Use in Depression TreatmentKathryn M Schak, Jennifer L Vande Voort, Emily K Johnson, et al.
Journal of Affective Disorders|January 10, 2019
Depressive symptoms carry an increased risk for suicidal ideation and behavior in bipolar disorder without any additional contribution of mixed symptomsJess G Fiedorowicz, Jane E Persons, Shervin Assari, et al.
Journal of Affective Disorders|January 19, 2007
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trialSusan L McElroy, Trisha Suppes, Mark A Frye, et al.
Bipolar Disorders|April 17, 2021
Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorderSusannah J Tye, Kristin Borreggine, J Blair Price, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 28, 2012
Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literatureAmit Chopra, Susannah J Tye, Kendall H Lee, et al.
Translational Psychiatry|April 25, 2020
Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideationCharles P Lewis, John D Port, Caren J Blacker, et al.
Journal of Clinical Psychopharmacology|November 3, 2016
Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol DependenceMark A Frye, David J Hinton, Victor M Karpyak, et al.
Pageof 52

Showing results (211-220 of 518) with videos related to

Sort By:
Pageof 52
Journal of Psychiatric Research|November 21, 2025
Prevalence of dermatologic side effects of mood stabilizers in bipolar disorder: A systematic review and meta-analysisFrancesca Pampaloni, Mete Ercis, Dawn Marie R Davis, et al.
Biological Psychiatry|February 8, 2025
A Critical Role of Philanthropic Support in Paving the Way to Precision Medicine for Bipolar DisorderDaniel L Pham, Emily G Baxi, Kelsey M Barcomb, et al.
Neuropharmacology|May 23, 2012
Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1David J Hinton, Moonnoh R Lee, Taylor L Jacobson, et al.
The American Journal of Psychiatry|March 2, 2016
Potential Risks of Poorly Monitored Ketamine Use in Depression TreatmentKathryn M Schak, Jennifer L Vande Voort, Emily K Johnson, et al.
Journal of Affective Disorders|January 10, 2019
Depressive symptoms carry an increased risk for suicidal ideation and behavior in bipolar disorder without any additional contribution of mixed symptomsJess G Fiedorowicz, Jane E Persons, Shervin Assari, et al.
Journal of Affective Disorders|January 19, 2007
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trialSusan L McElroy, Trisha Suppes, Mark A Frye, et al.
Bipolar Disorders|April 17, 2021
Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorderSusannah J Tye, Kristin Borreggine, J Blair Price, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 28, 2012
Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literatureAmit Chopra, Susannah J Tye, Kendall H Lee, et al.
Translational Psychiatry|April 25, 2020
Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideationCharles P Lewis, John D Port, Caren J Blacker, et al.
Journal of Clinical Psychopharmacology|November 3, 2016
Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol DependenceMark A Frye, David J Hinton, Victor M Karpyak, et al.
Pageof 52